soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL Study In the OASIS 4 phase

IntroductionThe surge in prescribing glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for diabetes and weight management highlights a pressing need to c...

In biochemical and preclinical research systems, GLP-RT interacts with three class B G protein-coupled receptors that regulate metabolic signaling networks: GLP-1R, GIPR, and GCGR

Looking for the perfect book to support your GLP-1 journey

Fayetteville, GA

This produces greater weight loss than Semaglutide alone says Dr Ambrish Mithal, Chairman, Endocrinology and Diabetes, Max Healthcare

Building a best-in-class automated de-identification tool for electronic health records through ensemble learning